Updated Jul 16, 2026
KARBE FRANK has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $99K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-21 | PHAT | Phathom Pharmaceuticals, Inc. | A — Grant or award | 24.1K | $0.00 | |
| 2025-06-03 | PHAT | Phathom Pharmaceuticals, Inc. | A — Grant or award | 10.5K | $0.00 | |
| 2024-12-16 | PHAT | Phathom Pharmaceuticals, Inc. | P — Open-market purchase | 12.5K | $7.93 | $99K |
KARBE FRANK is a corporate insider — currently tracked as Insider of Phathom Pharmaceuticals, Inc. (PHAT). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($99K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live KARBE FRANK profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.